Clinical trial
Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple…
NCT00185614 · Wen-Kai Weng, Other · Completed
Key facts
| NCT number | NCT00185614 |
|---|---|
| Title | Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma |
| Official title | Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma |
| Lead sponsor | Wen-Kai Weng, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Blood Cancer, Multiple Myeloma |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | Autologous hematopoietic cell transplant (Auto-HCT), Allogeneic hematopoietic cell transplant (Allo-HCT), Cyclophosphamide, Filgrastim, Melphalan, Total body irradiation (TBI), Cyclosporine (CSP), Mycophenolate Mofetil (MMF) |
| Enrollment | 63 |
| Start date | Aug 1, 2000 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2010 |
| First posted | Sep 16, 2005 |
| Last update posted | Jan 18, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: